Novel developments for treating brain disorders
This multidisciplinary four-day course covers all major neurobiological aspects related to traditional psychopharmacological treatments and new developments in drug modulation of brain function (including classical neuropsychopharmacological agents, cognitive enhancers, illicit drugs and nutraceuticals), its underlying mechanisms, as well as targetable biological systems and processes (microbiome & gut-brain axis, the blood-brain barrier and neuroinflammation). The four days cover topics related to: Psychiatry, Reward, Psychedelics and Aging and Cognition.
European Graduate School of Neuroscience (EURON)
University of Crete, Faculty of Medicine, Heraklion, Crete, Greece
University College Cork, Cork, Ireland
University of Minho, School of Medicine, Braga, Portugal